IC
CODX

IEQ Capital’s Co-Diagnostics CODX Stock Holding History

IEQ Capital’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-483
Closed -$47K – 834
2022
Q3 		$47K Hold
483
– – ﹤0.01% 827
2022
Q2 		$81K Hold
483
– – ﹤0.01% 773
2022
Q1 		$90K Hold
483
– – ﹤0.01% 791
2021
Q4 		$129K Buy
+483
New +$127K ﹤0.01% 707

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

IEQ Capital's CODX Position: Q4 2022 in Review

IEQ Capital sold out of Co-Diagnostics (CODX) in Q4 2022, closing a stake of 483 shares — an estimated $47K sold.

IEQ Capital first reported a position in CODX in Q4 2021 and held it in 4 quarters. The position peaked at $129K in Q4 2021. 60 funds tracked by Wall St. Rank hold CODX as of Q4 2022.

  • IEQ Capital reported no remaining Co-Diagnostics position as of Q4 2022 after selling out during the quarter.
  • IEQ Capital sold 483 Co-Diagnostics shares in Q4 2022, an estimated $47K.
  • IEQ Capital first reported a position in Co-Diagnostics in Q4 2021 and held it in 4 quarters.
  • IEQ Capital's Co-Diagnostics position peaked at $129K in Q4 2021.
  • 60 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2022.

Based on IEQ Capital's 13F filing for Q4 2022, filed 6 Feb 2023.